Cardiogenesis Transmyocardial Revascularization Registry

Completed

Conditions studied: Class IV Angina

In brief

The objectives of the registry are as follows: * Track "real world" performance outcomes and physician experience using the Cardiogenesis Laser System; * Further define the disease characteristics of the population being treated; * Examine transmyocardial revascularization (TMR) usage characteristics and 30-day outcomes; * Further assess the 30-day postoperative risk factors for adverse events. To limit the potential for bias, all patients eligible for TMR treatment who meet the Inclusion and Exclusion Criteria are to be offered the opportunity to enroll in the study at participating centers.

Key facts

Study ID
NCT01827319
Run by
Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
People needed
203
Starts
2013-05-01
Expected to finish
2015-06-01
Last updated by the study team
2016-08-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.